Skip to main content

Day: June 16, 2020

Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders

REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new independent directors, Alison Moore, Ph.D. and Stephen Dilly, MBBS, Ph.D. at the company’s 2020 Annual Meeting of Stockholders held earlier today.“We are delighted to welcome these two highly qualified professionals to our board, both of whom bring exceptional experience in biotherapeutics development and commercialization at a time when we are increasing our focus on this business segment,” said Bernard J. Kelley, Codexis Chairman.Dr. Moore brings to Codexis significant experience as a biotechnology and pharmaceutical executive, including an extensive background in biomanufacturing. She is Chief Technical Officer of Allogene Therapeutics,...

Continue reading

Domo Expands Snowflake Partnership to Help Customers Build Their Business in the Cloud

Introduces New Federated Query Capabilities Exclusively for SnowflakeJoins Snowflake’s Partner Connect Program and Offers Free Trial to Demonstrate the Future of Data through Mobile First Capabilities and Intelligent AppsSILICON SLOPES, Utah, June 16, 2020 (GLOBE NEWSWIRE) — Domo (Nasdaq: DOMO) today announced an expanded partnership with Snowflake, the cloud data platform, to help customers build their business in the cloud. As part of today’s news, Domo has joined the Snowflake Partner Connect Program and released new federated query capabilities, including a native setup experience, exclusively for Snowflake.  Joint customers can now more easily experience the future of data across their entire organization through Domo’s mobile-first design and intelligent apps.“Snowflake’s strong partner ecosystem is foundational to our mission...

Continue reading

Apex Global Brands Reports First Quarter 2021 Financial Results

First Quarter Fiscal 2021 Highlights versus First Quarter Fiscal 2020: Revenues declined to $4.0 million from $5.1 millionSG&A expenses declined to $2.9 million from $3.9 millionAdjusted EBITDA decreased slightly to $1.1 million from $1.2 millionNet loss of $1.8 million compared to a loss of $2.3 millionCOVID-19 Response Update:Expecting tax refunds of $9.0 million of previously paid federal taxes due to the CARES ActReceived a $0.7 million Paycheck Protection Program loan under the CARES ActExtended forbearance agreement with senior secured lender, including a suspension of interest and principal paymentsSHERMAN OAKS, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Apex Global Brands (Nasdaq: APEX), a global brand management and licensing organization that markets a portfolio of high-equity lifestyle brands it owns, creates and elevates,...

Continue reading

Emergent BioSolutions to Participate in Virtual Investor Conferences

GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences this month:BMO 2020 Prescriptions for Success Healthcare Virtual ConferenceJune 23 – fireside chat at 3:00 pm easternThree Part Advisors Virtual East Coast IDEAS Investor ConferenceJune 24 – pre-recorded presentation available for playback all day beginning at 8:00 am easternFor these conferences, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”About Emergent BioSolutionsEmergent...

Continue reading

Progenics Stockholders Approve Merger with Lantheus

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) (“Progenics”), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer, announced that at a special meeting of its stockholders held earlier today, Progenics’ stockholders voted to approve its proposed merger with Lantheus Holdings, Inc. (“Lantheus”), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, by adopting the previously announced Amended and Restated Agreement and Plan of Merger, dated as of February 20, 2020 (the “Merger Agreement”), by and among Progenics, Lantheus and Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (“Merger Sub”), pursuant to which Merger Sub will be merged with and into Progenics...

Continue reading

Sol-Gel to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference

NESS ZIONA, Israel, June 16, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced the company will present at the BMO 2020 Prescriptions for Success Healthcare Conference.        A live audio webcast will be available in the Investors/Events & Presentations section of the Sol-Gel Technologies website at http://ir.sol-gel.com/events-and-presentations. The webcast replay will also be available at the same link shortly after the conclusion of the event for 30 days.About Sol-Gel TechnologiesSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and...

Continue reading

PFSweb to Present at the 10th Annual East Coast IDEAS Virtual Investor Conference on June 24

ALLEN, Texas, June 16, 2020 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, will be presenting at the East Coast IDEAS Virtual Investor Conference, which is being held June 23-24, 2020. The presentation is scheduled to be available on Wednesday, June 24th starting at 8:00 a.m. Central time. It can be accessed here and via the investor relations section of the company’s website at www.pfsweb.com.For more information about the conference or to schedule a one-on-one meeting with PFSweb management, please contact your IDEAS conference representative or call the company’s investor relations team at 1-949-574-3860.About PFSweb, Inc.PFSweb (NASDAQ: PFSW) is a global commerce services company that manages the online customer shopping experience on behalf of major branded manufacturers and retailers....

Continue reading

Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the closing of its initial public offering of 17,968,750 shares of common stock, which includes the full exercise of the underwriters’ option to purchase 2,343,750 additional shares of common stock, at a public offering price of $16.00 per share. All of the shares were offered by Vaxcyte. The aggregate gross proceeds from the offering were $287.5 million, before deducting underwriting discounts and commissions and offering expenses. The shares began trading on the Nasdaq Global Select Market under the ticker symbol “PCVX” on June...

Continue reading

Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19 

TEMPLE CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today announced that it has launched an at-home testing solution for the Coronavirus Disease (COVID-19). The company has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for use in the United States.Fulgent Genetics will be offering the testing service through Picture Genetics, the company’s consumer-initiated genetic testing platform, beginning next week. Individuals interested in ordering testing services must qualify for the service through an online eligibility screener, which makes eligibility determinations based on current CDC guidelines while prioritizing those who are most in need of testing. Eligible...

Continue reading

WPT Industrial Real Estate Investment Trust Announces Results of Voting for Trustees at Annual Meeting of Unitholders and Provides Operational Update

TORONTO, June 16, 2020 (GLOBE NEWSWIRE) — WPT Industrial Real Estate Investment Trust (the “REIT”) (TSX: WIR.U; WIR.UN – OTCQX: WPTIF) announced today the results of voting for trustees at its annual meeting of unitholders held earlier today (the “Meeting”) and provided an operational update.VOTING RESULTSEach of the nominees listed in the management information circular dated May 13, 2020 was elected as a trustee of the REIT at the Meeting. On a vote conducted by ballot, the voting results were:Details of the voting results on all matters considered at the Meeting are available in the REIT’s report of voting results, which is available under the REIT’s profile on SEDAR at www.sedar.com.OPERATIONAL UPDATEThe REIT continues to closely monitor developments regarding the COVID-19 pandemic and work proactively to provide tenants...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.